The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2026 And What Value Is Projected For 2030?
The chronic obstructive pulmonary disease (copd) and asthma devices market size has experienced significant expansion in recent years. This market is forecasted to increase from $47.56 billion in 2025 to $50.3 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. The historical growth observed can be attributed to the rising prevalence of asthma and COPD, increasing air pollution and smoking rates, the growing use of inhalation therapy, the expansion of respiratory care services, and improved diagnosis of chronic respiratory diseases.
The chronic obstructive pulmonary disease (copd) and asthma devices market size is poised for robust expansion in the foreseeable future, with projections indicating it will climb to $62.83 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.7%. This growth over the forecast period is largely attributed to an aging population presenting higher respiratory risks, increasing demand for respiratory devices in home care settings, a rising understanding of early respiratory disease management, the expansion of programs focused on chronic disease management, and improved access to respiratory care within emerging markets. Notable trends anticipated during this period include a growing adoption of home-based respiratory care devices, an increasing demand for portable and user-friendly inhalation devices, a stronger emphasis on solutions for long-term disease management, the expanded use of devices across pediatric and geriatric demographics, and a heightened focus on treatment adherence and symptom control.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The increasing occurrence of respiratory conditions is projected to boost the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices market in the future. These respiratory conditions include various ailments impacting the lungs and respiratory systems, such as asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, all of which affect breathing and overall respiratory capacity. The rise in respiratory disease prevalence stems from factors like escalating air pollution, shifting climate patterns that influence allergens and pathogens, and lifestyle choices such as smoking, which negatively affect respiratory well-being. Devices for COPD and asthma are vital for the complete management and therapy of these diseases, helping patients attain improved respiratory health and enhance their general quality of life. As an illustration, data from December 2023, provided by the US-based government agency, the National Center for Biotechnology Information, indicated that COPD cases were anticipated to increase by 112 million, reaching a total of 592 million by 2050, accounting for 9.5% of the eligible population. Consequently, the surging prevalence of respiratory diseases fuels the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices markets.
What Are The Key Segments Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The chronic obstructive pulmonary disease (copd) and asthma devices market covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices
What Key Trends Are Influencing The Development Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Major companies operating in the chronic obstructive pulmonary disease and asthma devices market are prioritizing the development of innovative solutions, such as intelligent, sensor-equipped inhaler technologies, to boost medication adherence, enable live symptom tracking, and support personalized respiratory disease management. These smart inhaler technologies incorporate embedded sensors and digital connectivity features to capture inhalation data, observe patient usage patterns, and deliver actionable insights to both patients and clinicians. For instance, in July 2023, Teva UK Ltd., a UK-based pharmaceutical company, launched GoResp Digihaler, a digitally connected inhaler designed to record inhalation parameters, provide immediate feedback, and support enhanced disease control through data-driven patient engagement. This device helps improve treatment outcomes by enabling remote monitoring, offering clinicians greater visibility into patient adherence trends, and strengthening long-term disease management for individuals with chronic respiratory conditions.
Who Are The Leading Companies Operating In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Major companies operating in the chronic obstructive pulmonary disease (copd) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc., Aerogen Ltd
Read the full chronic obstructive pulmonary disease (copd) and asthma devices market report here:
What Are The Leading Geographic Regions In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2025. The regions covered in the chronic obstructive pulmonary disease (copd) and asthma devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp
Browse Through More Reports Similar to the Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market 2026, By The Business Research Company
High Performance Liquid Chromatography Market Report 2026
Analytical Laboratory Instrument Market Report 2026
Chromatography Software Market Report 2026
https://www.thebusinessresearchcompany.com/report/chromatography-software-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model